<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>21(2)</volume><submitter>Flores-Lagunes L</submitter><pubmed_abstract>Perry syndrome (PS) is a rare autosomal dominant disease characterized by parkinsonism, central hypoventilation, weight loss and depression and is caused by pathogenic mutations in the dynactin subunit 1 (&lt;i>DCTN1&lt;/i>) gene (encoding p150&lt;sup>glued&lt;/sup> protein). To date, only two cases have been reported in Latin America, specifically in Colombia and Argentina. The present study, to the best of our knowledge, reports the first recorded Mexican family with PS. The clinical features of the proband and a family history of early parkinsonism led to the suspicion of PS. The pathogenic variant NM_004082:c.212G>A, causing a (p.Gly71Glu) mutation in the p150&lt;sup>glued&lt;/sup> protein, was identified in exon 2 of the &lt;i>DCTN1&lt;/i> gene by exome sequencing, confirming the diagnosis of PS. (p.Gly71Glu</pubmed_abstract><journal>Biomedical reports</journal><pagination>120</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11229396</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>First family with Perry syndrome from Mexico.</pubmed_title><pmcid>PMC11229396</pmcid><pubmed_authors>Garcia-Solorio J</pubmed_authors><pubmed_authors>Alaez-Verson C</pubmed_authors><pubmed_authors>Molina-Garay C</pubmed_authors><pubmed_authors>Herrera GA</pubmed_authors><pubmed_authors>Flores-Lagunes L</pubmed_authors><pubmed_authors>Rodriguez Corona U</pubmed_authors><pubmed_authors>Ricardez-Marcial E</pubmed_authors><pubmed_authors>Del Pozo-Yauner L</pubmed_authors><pubmed_authors>Jimenez-Olivares M</pubmed_authors><pubmed_authors>Carrillo-Sanchez K</pubmed_authors></additional><is_claimable>false</is_claimable><name>First family with Perry syndrome from Mexico.</name><description>Perry syndrome (PS) is a rare autosomal dominant disease characterized by parkinsonism, central hypoventilation, weight loss and depression and is caused by pathogenic mutations in the dynactin subunit 1 (&lt;i>DCTN1&lt;/i>) gene (encoding p150&lt;sup>glued&lt;/sup> protein). To date, only two cases have been reported in Latin America, specifically in Colombia and Argentina. The present study, to the best of our knowledge, reports the first recorded Mexican family with PS. The clinical features of the proband and a family history of early parkinsonism led to the suspicion of PS. The pathogenic variant NM_004082:c.212G>A, causing a (p.Gly71Glu) mutation in the p150&lt;sup>glued&lt;/sup> protein, was identified in exon 2 of the &lt;i>DCTN1&lt;/i> gene by exome sequencing, confirming the diagnosis of PS. (p.Gly71Glu</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Aug</publication><modification>2026-06-01T13:36:21.609Z</modification><creation>2025-04-04T11:24:33.005Z</creation></dates><accession>S-EPMC11229396</accession><cross_references><pubmed>38978535</pubmed><doi>10.3892/br.2024.1808</doi></cross_references></HashMap>